BX-001N

· Bilix Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BX-001N, covering 2025-04-17 to 2025-09-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE) [Phase 2]

See pricing